FINALLY! An Ad Guaranteed Way to Make YOU $$$

Sunday, July 17, 2022

POTENTIAL NEW Anti-Thyroid-Cancer Treatment?

 "Thyroid cancer (TC) is the most common endocrine malignancy, and its global incidence has steadily increased over the past 15 years. TC is broadly divided into well-differentiated, poorly differentiated, and undifferentiated types, depending on the histological and clinical parameters. Thus far, there are no effective treatments for undifferentiated thyroid cancers or advanced and recurrent cancer."

Thus begins an NIH/PubMed paper which goes on to analyze the benefits of  Piperlongumine, a potent anti thyroid cancer drug which is actually just the extract of an Asian plant Long Pepper.

Research both in living animals and in the laboratory have shown this plant extract (available OTC as a supplement in places such as Amazon) blocks the life cycle of human thyroid cancer cells - and apparently ONLY those specific cells in that specific cancer.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428232/

This reminds me of the days before Malignant Melanoma treatments when I had to research obscure medical journals to find that Vitamin D-3 (and ONLY D-3) was the only treatment for the dangerous form of skin cancer.

"Does Vitamin D-3 Cure Malignant Melanoma?: How about curry? VITAL information directly from medical journals. (Collected Works: John A. McCormick Book 2) Kindle Edition"

($0.99 or free for Prime members - please note that hundreds of people read my medical blog and only ONE has ever helped me defray costs by purchasing or even reading one of my books for free. If you find some of this blog useful, even lifesaving, please consider showing your support before I get too disgusted and simply keep this sort of information to myself.)

In NO WAY do I recommend taking such remedies in place of sound medical treatments but sometimes there simply isn't any useful treatment such as chemotherapy. In such cases a safe supplement which is shown to be anti-cancer and which has no particular side effects is probably worth trying.

No comments:

Post a Comment